Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in Recurrent/Metastatic Breast Cancer
NCT00416130Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jan 2007
- Primary completion
- Jan 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in breast cancer, sponsored by National University Hospital. Status: unknown.
02
Drugs
vorinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00416130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416130.